In this study, direct sequencing was used to characterise the expression of the major species of SCCA variants in individual tumours and a new variant has been identified in about one third of the cases, which is 99% identical to SCCA1, but presents a G351 to A mutation in the reactive centre of the protein. This evidence concerns the gene SERPINB4 and neoplasm.